We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Effects of a Late Phase Exercise Program Following Total Hip Arthroplasty

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00896259
Recruitment Status : Completed
First Posted : May 11, 2009
Last Update Posted : August 29, 2012
Information provided by (Responsible Party):

Study Description
Brief Summary:

A group of orthopedic physiotherapists have developed a late phase program to educate and instruct total hip replacement patients in progressive exercises appropriate for their level of recovery. The components of this program include an educational presentation, individual assessment and exercise prescription. The investigators' intent is to pilot the program using a sample of patients. The objective of this pilot project:

To examine the effects of the late phase education session and home-based exercise program in restoring hip muscle strength, gait and function

Condition or disease Intervention/treatment
Total Hip Arthroplasty Other: home based exercise and education program

Study Design

Study Type : Observational
Actual Enrollment : 47 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Effects of a Late Phase Education and Exercise Program Following Total Hip Arthroplasty: A Pilot Project
Study Start Date : March 2009
Primary Completion Date : February 2011
Study Completion Date : February 2011

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
THA control
those with THA not participating in exercise and education program
THA exercise
those with THA and participating in exercise and education program
Other: home based exercise and education program
Individual assessment with physiotherapist with educational information, exercise instruction and prescription provided. Instructed to perform home exercises and walking for 12 weeks. Will be individually tailored to participants, bi-monthly phone calls will be used to monitor and facilitate exercise and walking progression .
healthy control
Healthy control, people with no lower limb gait abnormalities

Outcome Measures

Primary Outcome Measures :
  1. hip muscle strength [ Time Frame: 8-12 weeks post THA, 6-7 months post THA ]

Secondary Outcome Measures :
  1. Gait [ Time Frame: 8-12 weeks post THA, 6-7 months post THA ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
orthopedic clinic outpatients (of one clinic)

Inclusion Criteria:

  • unilateral primary total hip arthroplasty (THA)
  • 8-12 weeks post THA
  • over the age of 18
  • able to walk 15m without a walking aid
  • able to participate in an exercise program without physical assistance
  • available for follow up as per the study protocol
  • able to read and understand English and follow verbal and visual instructions

Exclusion Criteria:

  • medically unstable
  • have central or peripheral nervous system deficits
  • have an underlying terminal disease (cancer)
  • have suspicion of infection following joint replacement
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00896259

Canada, Nova Scotia
Orthopedic Clinic, QEII Health Sciences Centre, CDHA
Halifax, Nova Scotia, Canada, B3H 2E1
Sponsors and Collaborators
Nova Scotia Health Authority
Canadian Orthopaedic Foundation
Principal Investigator: Ann Read, BScPT, MSc CDHA
More Information

Responsible Party: Kim Parker, Rehabilitation Engineer, Capital District Health Authority, Canada
ClinicalTrials.gov Identifier: NCT00896259     History of Changes
Other Study ID Numbers: CDHA-RS/2007-057
First Posted: May 11, 2009    Key Record Dates
Last Update Posted: August 29, 2012
Last Verified: August 2012

Keywords provided by Kim Parker, Capital District Health Authority, Canada:
Unilateral total hip arthroplasty